Silk Road Medical to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
07 Fevereiro 2024 - 6:30PM
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on
reducing the risk of stroke and its devastating impact, today
announced it will report financial results for the fourth quarter
and full year 2023 after market close on Wednesday, February 28th,
2024. Company management will host a corresponding audio webcast
beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Those interested in listening to the conference call should
register online using this link. Participants are encouraged to
register more than 15 minutes before the start of the call. A live
and replay version of the webcast will be available at
https://investors.silkroadmed.com.
About Silk Road MedicalSilk Road Medical, Inc.
(NASDAQ: SILK), is a medical device company located in Sunnyvale,
California, and Plymouth, Minnesota, that is focused on reducing
the risk of stroke and its devastating impact. The company has
pioneered a new approach for the treatment of carotid artery
disease called TransCarotid Artery Revascularization (TCAR). TCAR
is a clinically proven procedure combining surgical principles of
neuroprotection with minimally invasive endovascular techniques to
treat blockages in the carotid artery at risk of causing a stroke.
For more information on how Silk Road Medical is delivering
brighter patient outcomes through brighter clinical thinking, visit
www.silkroadmed.com and connect on Twitter, LinkedIn and
Facebook.
Investor Contact:Marissa BychGilmartin
Groupinvestors@silkroadmed.com
Silk Road Medical (NASDAQ:SILK)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Silk Road Medical (NASDAQ:SILK)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024